A phase II trial of dose‑reduced nab‑paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302)

Shigeyuki Tamura,Hirokazu Taniguchi,Kazuhiro Nishikawa,Hiroshi Imamura,Junya Fujita,Atsushi Takeno,Jin Matsuyama,Yutaka Kimura,Junji Kawada,Motohiro Hirao,Masashi Hirota,Kazumasa Fujitani,Yukinori Kurokawa,Daisuke Sakai,Hisato Kawakami,Toshio Shimokawa,Taroh Satoh

International Journal of Clinical Oncology25,2035-2043(2020)